• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Events 30th International Symposium on Hepatitis C Virus, Flaviviruses, and Related Viruses

30th International Symposium on Hepatitis C Virus, Flaviviruses, and Related Viruses

September 25, 2024 – September 28, 2024

We are happy to announce that the 30th International Symposium on Hepatitis C Virus, Flaviviruses, and Related Viruses will take place in Oxford, UK from 25th – 28th September 2024.

September 25-28, Oxford, England

The annual HCV-Flavi Symposium is recognised internationally as the premier meeting for researchers working in the HCV and related flavivirus fields. Rotating through meeting venues in Europe, North America and Asia/Australia since 1994, the meeting has played a key role in both promoting excellence in research, driving discoveries in virus replication, pathogenesis and genetics, and providing the knowledge base for the spectacular advances in antiviral and vaccine development.

While HCV was originally the main focus of the symposium, its scope has been extended to include research on other flaviviruses such as dengue, yellow fever, West Nile and Zika viruses, pestiviruses, pegiviruses and related viruses. There are also fertile cross-disciplinary links with hepatitis E virus (HEV) research that has also fallen within the remit of the meeting in recent years. Their incorporation into the meeting programme reflects the huge scientific, public health and vaccine development effort in the wider virus family, and the valuable context and knowledge this brings to the HCV field – and conversely, the extraordinary virological and therapeutic progress on HCV that may cross-fertilise flavivirus and HEV research.

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.